UPDATE : Monday, August 10, 2020
Novo Nordisk Korea walks fine line marketing obesity drug
Novo Nordisk Korea raised some eyebrows ahead of launching its obesity drug...
by Marian Chu  |  2017-09-20 06:00
Samjin gets approval for phase 2 clinical trials for dry eye syndrome
Samjin Pharmaceuticals said Monday that it has received Ministry of Food an...
by Lee Han-soo  |  2017-09-19 18:03
Technology transfer to Genexine imminent
Genexine, which had brought anxiety to investors because of sudden stepdown...
by Nam Doo-hyun  |  2017-09-19 18:02
Prices of Viread's modified drugs plunge over past month
The domestic pharmaceutical companies’ plans to release the salt-altering p...
by Lee Hye-seon  |  2017-09-19 17:22
Kuhnil Pharmaceuticals succeed in phase 3 clinical trial for Atorvastatin
Kuhnil Pharmaceuticals said Tuesday that it has succeeded in phase 3 clinic...
by Lee Han-soo  |  2017-09-19 14:58
Global alliance project with Novo Nordisk opens in Korea
The Global Alliance Project with Novo Nordisk conference kicked off Monday ...
by Marian Chu  |  2017-09-18 17:14
Pharmaceutical industry leading new growth in Korea: report
The pharmaceutical industry is leading technological innovation and knowled...
by Nam Doo-hyun  |  2017-09-18 14:50
Opdivo adds one more melanoma indication
Ono Pharma Korea and Bristol-Myers Squibb Korea said Monday their anti PD-1...
by Marian Chu  |  2017-09-18 11:34
Korean pharmaceuticals challenge Pfizer’s Viviant with combination drugs
South Korean pharmaceutical firms are seeking ways to develop combination d...
by Lee Hye-seon  |  2017-09-18 11:26
HIRA’s drug pricing allegedly favors Green Cross, PMG Korea
The Korea Medical Clinic Association said Friday the Health Insurance Revie...
by Song Soo-youn  |  2017-09-15 17:58
Kolon uses Invossa to attract foreign patients
Kolon Life Science said it made a strategic MOU with Korea Tour Promotion A...
by Lee Hye-seon  |  2017-09-15 17:49
SK Chemicals’ release of test result abroad raises curiosity
SK Chemicals has released the results of its clinical trials of the overact...
by Lee Hye-seon  |  2017-09-15 17:39
Hanmi releases research result of new bio drug in Europe
Hanmi Pharmaceutical released the results of two new bio drugs the company ...
by Lee Hye-seon  |  2017-09-15 14:32
LG Chem promotes antidiabetic Zemiglo in Europe
LG Chemical has launched a symposium to promote its antidiabetics drug Zemi...
by Lee Hye-seon  |  2017-09-15 11:51
In historic move, FDA approves 1st biosimilar to treat cancer
The U.S. Food and Drug Administration Thursday marked a new page in cancer ...
by Marian Chu  |  2017-09-15 11:40
Huons to build new office
Huons Global said Wednesday that it plans to move its headquarters and R&D ...
by Lee Han-soo  |  2017-09-15 10:29
Daewoong wins rights to market hepatitis B treatment
Daewoong Pharmaceuticals대웅제약 (President Lee Jong-wook이종욱) said Thursday tha...
by Constance Williams  |  2017-09-14 19:37
NOAC race: Pradaxa prescription numbers fall behind fast followers
The first product to gain indications for a disease often maintains a domin...
by Marian Chu  |  2017-09-14 19:02
Opdivo vs. Keytruda - which will doctors choose?
Two blockbuster immunotherapies Opdivo and Keytruda gained insurance covera...
by Marian Chu  |  2017-09-14 17:54
Chong Kun Dang enters an osteoporosis therapy market
Chong Kun Dang has entered an osteoporosis therapy market with Prolia (comp...
by Lee Hye-seon  |  2017-09-14 17:53
Back to Top